| __timestamp | Catalent, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1827700000 | 122045000 |
| Thursday, January 1, 2015 | 1830800000 | 144427000 |
| Friday, January 1, 2016 | 1848100000 | 215003000 |
| Sunday, January 1, 2017 | 2075400000 | 302238000 |
| Monday, January 1, 2018 | 2463400000 | 408897000 |
| Tuesday, January 1, 2019 | 2518000000 | 392755000 |
| Wednesday, January 1, 2020 | 3094300000 | 520397000 |
| Friday, January 1, 2021 | 3998000000 | 579775000 |
| Saturday, January 1, 2022 | 4828000000 | 667238000 |
| Sunday, January 1, 2023 | 4276000000 | 607521000 |
| Monday, January 1, 2024 | 4381000000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Catalent, Inc. has demonstrated a robust upward trajectory, with revenue increasing by approximately 140% from 2014 to 2024. This growth is highlighted by a peak in 2022, where revenue reached nearly $4.8 billion. In contrast, Supernus Pharmaceuticals, Inc. has shown a steady, albeit more modest, growth of around 450% over the same period, peaking in 2022 with revenue of about $667 million.
These insights provide a snapshot of how these companies have navigated the evolving pharmaceutical market over the past decade.
Johnson & Johnson and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: AbbVie Inc. vs Catalent, Inc.
Comparing Revenue Performance: Sanofi or Catalent, Inc.?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Incyte Corporation or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Revenue Insights: Catalent, Inc. and Corcept Therapeutics Incorporated Performance Compared
Revenue Showdown: Catalent, Inc. vs TG Therapeutics, Inc.
Revenue Insights: Catalent, Inc. and Mesoblast Limited Performance Compared
Catalent, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Supernus Pharmaceuticals, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared